Compare Halozyme Therapeutics Inc. Common Stock (HALO) vs UBS Group AG Registered Ordinary Shares (UBS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Halozyme Therapeutics Inc. Common Stock vs UBS Group AG Registered Ordinary Shares — how do they compare? Halozyme Therapeutics Inc. Common Stock trades at $112.45 (market cap $12.58B), while UBS Group AG Registered Ordinary Shares trades at $48.16 (market cap $142.70B). The key difference: UBS Group AG Registered Ordinary Shares is far larger — about 11.3× Halozyme Therapeutics Inc. Common Stock's market cap, and UBS Group AG Registered Ordinary Shares pays a 2.34% dividend while Halozyme Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Halozyme Therapeutics Inc. Common Stock for 0 Days and UBS Group AG Registered Ordinary Shares for 1 Days on average.
| HALO | UBS | |
|---|---|---|
Market Cap | $12.58B | $142.70B |
Volume | 2,179,278 | 2,096,090 |
Sector | Health | Financials |
52-Week High | $115.22 | $55.72 |
52-Week Low | $61.63 | $36.41 |
Typical Hold Time | 0 Days | 1 Days |
Enterprise Value | $14.49B | $314.41B |
Dividend Yield | — | 2.34% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →About UBS Group AG Registered Ordinary Shares
UBS is a global financial services company focused on wealth management, investment banking, and asset management. It serves private, corporate, and institutional clients.
Read more on UBS →
